Syndax Pharmaceuticals, Inc.
SNDXBiotechnology
$14.15−1.19%As of Oct 29vs prior close
- Market cap
- $1.3B
- P/E (TTM)
- –
- From 52W high
- −43.74%
- EPS (LTM)
- -$2.51
- Revenue (LTM)
- $252M
- Net margin
- -87.60%
- Dividend yield
- 0.00%
Nomior Score
53
Ascendant MoverTop 44% of the scored universe
Growth71
Quality44
Value52
Momentum68
Resilience27
Growth
+73.34%revenue a year over 9 fiscal years
YE16 $1.2MLTM $252M
Connections
Revenue to profitQ2 YE26
The operating loss was 55% of revenue, narrower by 128 pts on a year.
Who owns it
2funds, 1 tracked portfolio